Latest news
Maze Therapeutics (NASDAQ:MAZE) Trading Down 6.8% - Should You Sell? - MarketBeatMarketBeat · Mon, 10 Aug 2026 19:38:28 GMTMaze Therapeutics Inc (MAZE) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKeyTradingKey · Fri, 07 Aug 2026 14:29:07 GMTMaze Therapeutics, Inc. (MAZE) CEO Coloma sells 34,501 shares via trusts - Stock TitanStock Titan · Wed, 05 Aug 2026 20:09:36 GMTMAZE (NASDAQ: MAZE) insider trusts detail stock sales in Form 144 - Stock TitanStock Titan · Mon, 03 Aug 2026 20:09:41 GMTMaze Therapeutics, Inc. $MAZE Stake Reduced by Janus Henderson Group PLC - MarketBeatMarketBeat · Sat, 01 Aug 2026 10:42:24 GMTMAZE PE Ratio & Valuation, Is MAZE Overvalued - Intellectia AIIntellectia AI · Sat, 01 Aug 2026 01:57:10 GMTMaze Therapeutics (MAZE) insider exercises 7,500 options, sells 7,500 shares - Stock TitanStock Titan · Fri, 31 Jul 2026 07:00:00 GMTInsider Selling: Maze Therapeutics (NASDAQ:MAZE) Insider Sells $205,050.00 in Stock - MarketBeatMarketBeat · Fri, 31 Jul 2026 07:00:00 GMT